Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease. Academic Article uri icon

Overview

publication date

  • September 1, 2023

Research

keywords

  • Crohn Disease
  • Ustekinumab

Identity

Scopus Document Identifier

  • 85158135122

Digital Object Identifier (DOI)

  • 10.1093/ibd/izac236

PubMed ID

  • 36421052

Additional Document Info

volume

  • 29

issue

  • 9